関: antispasmodic agent、antispasmodic drug、antispasmodics、parasympatholytic、spasmolytic

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/10/11 18:43:02」(JST)

wiki en

A parasympatholytic agent is a substance or activity that reduces the activity of the parasympathetic nervous system.^[1] (The parasympathetic nervous system is often colloquially described as the "Feed and Breed" or "Rest and Digest" portion of the autonomic nervous system. The parasympathetic nervous system becomes strongly engaged during or after a meal and during times when the body is at rest.)

The term parasympatholytic typically refers to the effect of a drug, although some poisons act to block the parasympathetic nervous system as well. Most drugs with parasympatholytic properties are anticholinergics.

"Parasympatholytic" and sympathomimetic agents have similar but not identical effects. For example, both cause mydriasis, but parasympatholytics reduce accommodation (cycloplegia), whereas sympathomimetics do not.

Clinical significance

Parasympatholytic drugs are sometimes used to treat slow heart rhythms (bradycardias or bradydysrhythmias) caused by myocardial infarctions or other pathologies, as well as to treat conditions that cause bronchioles in the lung to constrict, such as asthma. By blocking the parasympathetic nervous system, parasympatholytic drugs can increase heart rate in patients with bradycardic heart rhythms, and open up airways and reduce mucous production in patients suffering from asthma.

Main Article: Anticholinergic

References

^ "Dorlands Medical Dictionary:parasympatholytic". http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/six/000078651.htm.

External links

Overview at salisbury.edu
Parasympatholytics at the US National Library of Medicine Medical Subject Headings (MeSH)

This medical article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 抗コリン剤中毒 anticholinergic poisoning
2. 慢性閉塞性肺疾患（COPD）における抗コリン療法の役割 role of anticholinergic therapy in copd
3. 女性における尿失禁の治療 treatment of urinary incontinence in women
4. Amblyopia in children: Management and outcome
5. 高齢者に対する薬剤処方 drug prescribing for older adults

English Journal

Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.

Wechsler ME1, Yawn BP2, Fuhlbrigge AL3, Pace WD4, Pencina MJ5, Doros G6, Kazani S7, Raby BA3, Lanzillotti J8, Madison S2, Israel E3; BELT Investigators.
JAMA.JAMA.2015 Oct 27;314(16):1720-30. doi: 10.1001/jama.2015.13277.
IMPORTANCE: The efficacy and safety of long-acting β-agonists (LABAs) have been questioned. Black populations may be disproportionately affected by LABA risks.OBJECTIVE: To compare the effectiveness and safety of tiotropium vs LABAs, when used with inhaled corticosteroids (ICS) in black adults with
PMID 26505596

Pharmacologic Agents for Chronic Diarrhea.

Lee KJ1.
Intestinal research.Intest Res.2015 Oct;13(4):306-12. doi: 10.5217/ir.2015.13.4.306. Epub 2015 Oct 15.
Chronic diarrhea is usually associated with a number of non-infectious causes. When definitive treatment is unavailable, symptomatic drug therapy is indicated. Pharmacologic agents for chronic diarrhea include loperamide, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists, diosmectite, cholesty
PMID 26576135

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H1, Lear-Rooney CM2, Johansen L3, Varhegyi E1, Chen ZW1, Olinger GG2, Rong L4.
Journal of virology.J Virol.2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22.
Filoviruses, consisting of Ebola virus (EBOV) and Marburg virus (MARV), are among the most lethal infectious threats to mankind. Infections by these viruses can cause severe hemorrhagic fevers in humans and nonhuman primates with high mortality rates. Since there is currently no vaccine or antiviral
PMID 26202243